Patient-Derived Tumor Xenograft and Organoid Models Established from Resected Pancreatic, Duodenal and Biliary Cancers

0
148
Patient-derived xenograft models were established from 276 pancreato-duodenal and biliary cancer resections. Pancreatic ductal adenocarcinoma (PDAC), had a P0 engraftment rate of 62%.
[Scientific Reports]
Pham, N.-A., Radulovich, N., Ibrahimov, E., Martins-Filho, S. N., Li, Q., Pintilie, M., Weiss, J., Raghavan, V., Cabanero, M., Denroche, R. E., Wilson, J. M., Metran-Nascente, C., Borgida, A., Hutchinson, S., Dodd, A., Begora, M., Chadwick, D., Serra, S., Knox, J. J., … Tsao, M.-S. (2021). Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers. Scientific Reports, 11(1), 10619. https://doi.org/10.1038/s41598-021-90049-1 Cite
Full Article